Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular, Molecular, and Tumor Biology 73: Regulation of TRAIL-induced Apoptosis

Uncouplers of oxidative phosphorylation sensitize resistant colon carcinoma cell lines (cc) to the cytotoxic ligand TRAIL.

Kamel Izeradjene, Leslie Douglas, David M. Tillman and Janet A. Houghton
Kamel Izeradjene
SJCRH, Memphis, TN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie Douglas
SJCRH, Memphis, TN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Tillman
SJCRH, Memphis, TN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet A. Houghton
SJCRH, Memphis, TN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2004
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 45, 2004

Abstract

3582

During apoptosis, the permeabilization of the mitochondrial outer membrane allows the release of proapoptotic factors (cytochrome c, Smac/DIABLO, HtrA2/Omi), which induce cell death. Mitochondria rapidly lose their transmembrane potential (Δ Ψm) and generate reactive oxygen species (ROS), both of which can contribute to dismantling of the cell. We have demonstrated that an uncoupler of oxidative phosphorylation, carbonyl cyanide m-chlorophenylhydrazone (CCCP), enhances the apoptosis-inducing capacity of TRAIL in TRAIL-resistant cc (RKO, HT29, SW480). This sensitization was inhibited by zVAD-fmk, indicating the requirement for caspase activation. In RKO, CCCP induced loss of ΔΨm without release of proapoptotic factors from the mitochondria. Overexpression of Bcl-2 did not prevent the initial loss of ΔΨm following CCCP treatment, but did prevent further decrease in ΔΨm and cell death following TRAIL+CCCP exposure. Treatment of RKO cells with TRAIL+CCCP resulted in 1) enhanced caspase-8 activation, cleavage of Bid and Bax conformational change, 2) release of cytochrome c, Smac/DIABLO and HtrA2/Omi into the cytosol, and 3) subsequent caspase-3 activation, PARP cleavage and apoptosis. Degradation of XIAP appeared critical, as it occurred only when mitochondrial apoptotic pathways were activated, as reflected by Smac/DIABLO, HtrA2/Omi, and cytochrome c release after TRAIL + CCCP treatment. Of interest, caspase-9 was activated to the same extent when cells were treated with TRAIL +/− CCCP. Overexpression of a mutant caspase-9 did not protect RKO cells from TRAIL+CCCP-induced apoptosis, indicating that apoptosis occurred via a caspase-9-independent pathway. Since cytochrome c is a key factor in caspase-9 activation, non involvement of caspase-9 in the apoptotic pathway indicated that the major mitochondrial pro-apoptotic factors involved in apoptosis were Smac/DIABLO and/or HtrA2/Omi. In addition to loss in ΔΨm, CCCP induced a pronounced increase in ROS production, not prevented by overexpression of Bcl-2. In Bcl-2-expressing cells, ROS production was sustained while in control transfected cells, ROS production was disrupted, correlating with the further decrease in ΔΨm following TRAIL+CCCP treatment. Preincubation of RKO with antioxidants (N-acetyl-L-cysteine or GSH) completely abrogated TRAIL+CCCP-induced apoptosis, production of ROS and loss in ΔΨm. Results also demonstrated that caspase-8 was not cleaved after TRAIL+CCCP in the presence of N-acetyl-L-cysteine, indicating that TRAIL induced caspase-8 activation in a ROS-dependent manner. Data suggest that cellular resistance to TRAIL is modulated by the redox state and by mitochondrial-derived ROS. Supported by NCI awards CA 32613, CA 21765 and by ALSAC.

  • American Association for Cancer Research
Previous
Back to top
April 2004
Volume 64, Issue 7 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Uncouplers of oxidative phosphorylation sensitize resistant colon carcinoma cell lines (cc) to the cytotoxic ligand TRAIL.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Uncouplers of oxidative phosphorylation sensitize resistant colon carcinoma cell lines (cc) to the cytotoxic ligand TRAIL.
Kamel Izeradjene, Leslie Douglas, David M. Tillman and Janet A. Houghton
Cancer Res April 1 2004 (64) (7 Supplement) 826;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Uncouplers of oxidative phosphorylation sensitize resistant colon carcinoma cell lines (cc) to the cytotoxic ligand TRAIL.
Kamel Izeradjene, Leslie Douglas, David M. Tillman and Janet A. Houghton
Cancer Res April 1 2004 (64) (7 Supplement) 826;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Acquired TRAIL-resistance in mismatch repair proficient colon carcinoma cell lines.
  • Wnt pathway activation in colorectal tumors is associated with an increase in DR4 expression.
Show more Cellular, Molecular, and Tumor Biology 73: Regulation of TRAIL-induced Apoptosis
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement